nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—TLR4—ankylosing spondylitis	0.0686	1	CrCbGaD
Nalbuphine—Foetal death—Methotrexate—ankylosing spondylitis	0.0555	0.0596	CcSEcCtD
Nalbuphine—Speech impairment NOS—Methotrexate—ankylosing spondylitis	0.0293	0.0315	CcSEcCtD
Nalbuphine—Delusion—Methylprednisolone—ankylosing spondylitis	0.0137	0.0147	CcSEcCtD
Nalbuphine—Delusion—Betamethasone—ankylosing spondylitis	0.0124	0.0133	CcSEcCtD
Nalbuphine—Delusion—Dexamethasone—ankylosing spondylitis	0.0124	0.0133	CcSEcCtD
Nalbuphine—Tingling sensation—Methylprednisolone—ankylosing spondylitis	0.012	0.0129	CcSEcCtD
Nalbuphine—Tingling sensation—Dexamethasone—ankylosing spondylitis	0.0109	0.0117	CcSEcCtD
Nalbuphine—Tingling sensation—Betamethasone—ankylosing spondylitis	0.0109	0.0117	CcSEcCtD
Nalbuphine—Delusion—Prednisone—ankylosing spondylitis	0.0108	0.0116	CcSEcCtD
Nalbuphine—Wheezing—Triamcinolone—ankylosing spondylitis	0.00941	0.0101	CcSEcCtD
Nalbuphine—Pulmonary oedema—Prednisolone—ankylosing spondylitis	0.00938	0.0101	CcSEcCtD
Nalbuphine—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00905	0.00972	CcSEcCtD
Nalbuphine—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.00863	0.00926	CcSEcCtD
Nalbuphine—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.00861	0.00924	CcSEcCtD
Nalbuphine—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.00833	0.00894	CcSEcCtD
Nalbuphine—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.00831	0.00892	CcSEcCtD
Nalbuphine—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.00783	0.0084	CcSEcCtD
Nalbuphine—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.00783	0.0084	CcSEcCtD
Nalbuphine—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00756	0.00811	CcSEcCtD
Nalbuphine—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00756	0.00811	CcSEcCtD
Nalbuphine—Speech disorder—Methotrexate—ankylosing spondylitis	0.00744	0.00799	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00727	0.00781	CcSEcCtD
Nalbuphine—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.00682	0.00732	CcSEcCtD
Nalbuphine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00669	0.00718	CcSEcCtD
Nalbuphine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00667	0.00717	CcSEcCtD
Nalbuphine—Euphoric mood—Prednisone—ankylosing spondylitis	0.00658	0.00706	CcSEcCtD
Nalbuphine—Sweating increased—Prednisolone—ankylosing spondylitis	0.00644	0.00692	CcSEcCtD
Nalbuphine—Asthma—Triamcinolone—ankylosing spondylitis	0.00608	0.00653	CcSEcCtD
Nalbuphine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00607	0.00652	CcSEcCtD
Nalbuphine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00607	0.00652	CcSEcCtD
Nalbuphine—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00597	0.00641	CcSEcCtD
Nalbuphine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00592	0.00636	CcSEcCtD
Nalbuphine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00591	0.00635	CcSEcCtD
Nalbuphine—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.0057	0.00612	CcSEcCtD
Nalbuphine—Bradycardia—Prednisolone—ankylosing spondylitis	0.00539	0.00578	CcSEcCtD
Nalbuphine—Sweating increased—Betamethasone—ankylosing spondylitis	0.00537	0.00577	CcSEcCtD
Nalbuphine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00537	0.00577	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00529	0.00568	CcSEcCtD
Nalbuphine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00495	0.00532	CcSEcCtD
Nalbuphine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00494	0.00531	CcSEcCtD
Nalbuphine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00483	0.00519	CcSEcCtD
Nalbuphine—Sweating increased—Prednisone—ankylosing spondylitis	0.00468	0.00503	CcSEcCtD
Nalbuphine—Erythema—Prednisolone—ankylosing spondylitis	0.00461	0.00495	CcSEcCtD
Nalbuphine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.0045	0.00483	CcSEcCtD
Nalbuphine—Bradycardia—Betamethasone—ankylosing spondylitis	0.0045	0.00483	CcSEcCtD
Nalbuphine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00439	0.00472	CcSEcCtD
Nalbuphine—Hallucination—Betamethasone—ankylosing spondylitis	0.00439	0.00472	CcSEcCtD
Nalbuphine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00434	0.00466	CcSEcCtD
Nalbuphine—Depression—Prednisone—ankylosing spondylitis	0.00427	0.00459	CcSEcCtD
Nalbuphine—Erythema—Triamcinolone—ankylosing spondylitis	0.00424	0.00455	CcSEcCtD
Nalbuphine—Erythema—Methylprednisolone—ankylosing spondylitis	0.00423	0.00454	CcSEcCtD
Nalbuphine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00415	0.00445	CcSEcCtD
Nalbuphine—Vertigo—Prednisolone—ankylosing spondylitis	0.00414	0.00444	CcSEcCtD
Nalbuphine—Syncope—Prednisolone—ankylosing spondylitis	0.00413	0.00444	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00405	0.00435	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—ankylosing spondylitis	0.00402	0.00431	CcSEcCtD
Nalbuphine—Convulsion—Prednisolone—ankylosing spondylitis	0.00399	0.00429	CcSEcCtD
Nalbuphine—Hypertension—Prednisolone—ankylosing spondylitis	0.00398	0.00427	CcSEcCtD
Nalbuphine—Bradycardia—Prednisone—ankylosing spondylitis	0.00391	0.0042	CcSEcCtD
Nalbuphine—Erythema—Dexamethasone—ankylosing spondylitis	0.00384	0.00413	CcSEcCtD
Nalbuphine—Erythema—Betamethasone—ankylosing spondylitis	0.00384	0.00413	CcSEcCtD
Nalbuphine—Hallucination—Prednisone—ankylosing spondylitis	0.00383	0.00411	CcSEcCtD
Nalbuphine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00381	0.00409	CcSEcCtD
Nalbuphine—Syncope—Triamcinolone—ankylosing spondylitis	0.0038	0.00408	CcSEcCtD
Nalbuphine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.0038	0.00408	CcSEcCtD
Nalbuphine—Syncope—Methylprednisolone—ankylosing spondylitis	0.00379	0.00407	CcSEcCtD
Nalbuphine—Oedema—Prednisolone—ankylosing spondylitis	0.00376	0.00404	CcSEcCtD
Nalbuphine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00372	0.004	CcSEcCtD
Nalbuphine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00372	0.00399	CcSEcCtD
Nalbuphine—Shock—Prednisolone—ankylosing spondylitis	0.0037	0.00397	CcSEcCtD
Nalbuphine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00367	0.00394	CcSEcCtD
Nalbuphine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00367	0.00394	CcSEcCtD
Nalbuphine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00366	0.00393	CcSEcCtD
Nalbuphine—Hypertension—Triamcinolone—ankylosing spondylitis	0.00366	0.00393	CcSEcCtD
Nalbuphine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00365	0.00392	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00363	0.0039	CcSEcCtD
Nalbuphine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00359	0.00385	CcSEcCtD
Nalbuphine—Depression—Methotrexate—ankylosing spondylitis	0.00357	0.00383	CcSEcCtD
Nalbuphine—Flushing—Prednisone—ankylosing spondylitis	0.00357	0.00383	CcSEcCtD
Nalbuphine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00353	0.00379	CcSEcCtD
Nalbuphine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00348	0.00373	CcSEcCtD
Nalbuphine—Oedema—Triamcinolone—ankylosing spondylitis	0.00346	0.00371	CcSEcCtD
Nalbuphine—Vertigo—Betamethasone—ankylosing spondylitis	0.00345	0.00371	CcSEcCtD
Nalbuphine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00345	0.00371	CcSEcCtD
Nalbuphine—Syncope—Dexamethasone—ankylosing spondylitis	0.00345	0.0037	CcSEcCtD
Nalbuphine—Syncope—Betamethasone—ankylosing spondylitis	0.00345	0.0037	CcSEcCtD
Nalbuphine—Shock—Triamcinolone—ankylosing spondylitis	0.0034	0.00365	CcSEcCtD
Nalbuphine—Shock—Methylprednisolone—ankylosing spondylitis	0.00339	0.00364	CcSEcCtD
Nalbuphine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00338	0.00363	CcSEcCtD
Nalbuphine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00338	0.00363	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00338	0.00362	CcSEcCtD
Nalbuphine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00337	0.00362	CcSEcCtD
Nalbuphine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00337	0.00362	CcSEcCtD
Nalbuphine—Erythema—Prednisone—ankylosing spondylitis	0.00335	0.00359	CcSEcCtD
Nalbuphine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00334	0.00359	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00334	0.00358	CcSEcCtD
Nalbuphine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00333	0.00358	CcSEcCtD
Nalbuphine—Convulsion—Betamethasone—ankylosing spondylitis	0.00333	0.00358	CcSEcCtD
Nalbuphine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00332	0.00356	CcSEcCtD
Nalbuphine—Hypertension—Betamethasone—ankylosing spondylitis	0.00332	0.00356	CcSEcCtD
Nalbuphine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00326	0.0035	CcSEcCtD
Nalbuphine—Anxiety—Betamethasone—ankylosing spondylitis	0.00326	0.0035	CcSEcCtD
Nalbuphine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00322	0.00346	CcSEcCtD
Nalbuphine—Vision blurred—Prednisone—ankylosing spondylitis	0.00315	0.00339	CcSEcCtD
Nalbuphine—Oedema—Dexamethasone—ankylosing spondylitis	0.00314	0.00337	CcSEcCtD
Nalbuphine—Oedema—Betamethasone—ankylosing spondylitis	0.00314	0.00337	CcSEcCtD
Nalbuphine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.0031	0.00333	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0031	0.00333	CcSEcCtD
Nalbuphine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.0031	0.00333	CcSEcCtD
Nalbuphine—Shock—Betamethasone—ankylosing spondylitis	0.00309	0.00331	CcSEcCtD
Nalbuphine—Shock—Dexamethasone—ankylosing spondylitis	0.00309	0.00331	CcSEcCtD
Nalbuphine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00308	0.00331	CcSEcCtD
Nalbuphine—Agitation—Prednisone—ankylosing spondylitis	0.00308	0.0033	CcSEcCtD
Nalbuphine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00306	0.00329	CcSEcCtD
Nalbuphine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00306	0.00329	CcSEcCtD
Nalbuphine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00304	0.00327	CcSEcCtD
Nalbuphine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00304	0.00326	CcSEcCtD
Nalbuphine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00303	0.00326	CcSEcCtD
Nalbuphine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00303	0.00326	CcSEcCtD
Nalbuphine—Vertigo—Prednisone—ankylosing spondylitis	0.00301	0.00323	CcSEcCtD
Nalbuphine—Syncope—Prednisone—ankylosing spondylitis	0.003	0.00322	CcSEcCtD
Nalbuphine—Urticaria—Prednisolone—ankylosing spondylitis	0.00299	0.00321	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00294	0.00316	CcSEcCtD
Nalbuphine—Hypotension—Dexamethasone—ankylosing spondylitis	0.00293	0.00315	CcSEcCtD
Nalbuphine—Hypotension—Betamethasone—ankylosing spondylitis	0.00293	0.00315	CcSEcCtD
Nalbuphine—Convulsion—Prednisone—ankylosing spondylitis	0.0029	0.00311	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—ankylosing spondylitis	0.00289	0.0031	CcSEcCtD
Nalbuphine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00285	0.00306	CcSEcCtD
Nalbuphine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00284	0.00305	CcSEcCtD
Nalbuphine—Anxiety—Prednisone—ankylosing spondylitis	0.00284	0.00305	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00282	0.00303	CcSEcCtD
Nalbuphine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00282	0.00302	CcSEcCtD
Nalbuphine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00282	0.00302	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—ankylosing spondylitis	0.0028	0.003	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00277	0.00297	CcSEcCtD
Nalbuphine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00276	0.00297	CcSEcCtD
Nalbuphine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00276	0.00297	CcSEcCtD
Nalbuphine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00275	0.00295	CcSEcCtD
Nalbuphine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00274	0.00294	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00274	0.00294	CcSEcCtD
Nalbuphine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00273	0.00293	CcSEcCtD
Nalbuphine—Oedema—Prednisone—ankylosing spondylitis	0.00273	0.00293	CcSEcCtD
Nalbuphine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00273	0.00293	CcSEcCtD
Nalbuphine—Shock—Prednisone—ankylosing spondylitis	0.00269	0.00289	CcSEcCtD
Nalbuphine—Tachycardia—Prednisone—ankylosing spondylitis	0.00267	0.00286	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00264	0.00284	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00264	0.00283	CcSEcCtD
Nalbuphine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00259	0.00278	CcSEcCtD
Nalbuphine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00259	0.00278	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00257	0.00275	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00257	0.00275	CcSEcCtD
Nalbuphine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00255	0.00274	CcSEcCtD
Nalbuphine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00254	0.00273	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—ankylosing spondylitis	0.00251	0.0027	CcSEcCtD
Nalbuphine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00249	0.00268	CcSEcCtD
Nalbuphine—Urticaria—Betamethasone—ankylosing spondylitis	0.00249	0.00268	CcSEcCtD
Nalbuphine—Dizziness—Prednisolone—ankylosing spondylitis	0.00249	0.00267	CcSEcCtD
Nalbuphine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00248	0.00266	CcSEcCtD
Nalbuphine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00248	0.00266	CcSEcCtD
Nalbuphine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00248	0.00266	CcSEcCtD
Nalbuphine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00248	0.00266	CcSEcCtD
Nalbuphine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00248	0.00266	CcSEcCtD
Nalbuphine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00248	0.00266	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00245	0.00263	CcSEcCtD
Nalbuphine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00245	0.00263	CcSEcCtD
Nalbuphine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00244	0.00262	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—ankylosing spondylitis	0.00242	0.0026	CcSEcCtD
Nalbuphine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00241	0.00258	CcSEcCtD
Nalbuphine—Rash—Prednisolone—ankylosing spondylitis	0.00237	0.00255	CcSEcCtD
Nalbuphine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00237	0.00254	CcSEcCtD
Nalbuphine—Headache—Prednisolone—ankylosing spondylitis	0.00236	0.00253	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—ankylosing spondylitis	0.0023	0.00247	CcSEcCtD
Nalbuphine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00229	0.00245	CcSEcCtD
Nalbuphine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00228	0.00245	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00225	0.00242	CcSEcCtD
Nalbuphine—Asthenia—Betamethasone—ankylosing spondylitis	0.00225	0.00242	CcSEcCtD
Nalbuphine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00225	0.00242	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00223	0.0024	CcSEcCtD
Nalbuphine—Nausea—Prednisolone—ankylosing spondylitis	0.00223	0.0024	CcSEcCtD
Nalbuphine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00222	0.00238	CcSEcCtD
Nalbuphine—Pruritus—Betamethasone—ankylosing spondylitis	0.00222	0.00238	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00221	0.00237	CcSEcCtD
Nalbuphine—Vomiting—Triamcinolone—ankylosing spondylitis	0.0022	0.00236	CcSEcCtD
Nalbuphine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00219	0.00236	CcSEcCtD
Nalbuphine—Rash—Triamcinolone—ankylosing spondylitis	0.00218	0.00234	CcSEcCtD
Nalbuphine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00218	0.00234	CcSEcCtD
Nalbuphine—Rash—Methylprednisolone—ankylosing spondylitis	0.00218	0.00234	CcSEcCtD
Nalbuphine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00217	0.00233	CcSEcCtD
Nalbuphine—Urticaria—Prednisone—ankylosing spondylitis	0.00217	0.00233	CcSEcCtD
Nalbuphine—Headache—Triamcinolone—ankylosing spondylitis	0.00217	0.00233	CcSEcCtD
Nalbuphine—Headache—Methylprednisolone—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—ankylosing spondylitis	0.00213	0.00229	CcSEcCtD
Nalbuphine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00207	0.00223	CcSEcCtD
Nalbuphine—Dizziness—Betamethasone—ankylosing spondylitis	0.00207	0.00223	CcSEcCtD
Nalbuphine—Nausea—Triamcinolone—ankylosing spondylitis	0.00205	0.00221	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00205	0.0022	CcSEcCtD
Nalbuphine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00205	0.0022	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00204	0.00219	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—ankylosing spondylitis	0.00203	0.00218	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00201	0.00216	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00201	0.00216	CcSEcCtD
Nalbuphine—Vomiting—Betamethasone—ankylosing spondylitis	0.00199	0.00214	CcSEcCtD
Nalbuphine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00199	0.00214	CcSEcCtD
Nalbuphine—Rash—Betamethasone—ankylosing spondylitis	0.00198	0.00212	CcSEcCtD
Nalbuphine—Rash—Dexamethasone—ankylosing spondylitis	0.00198	0.00212	CcSEcCtD
Nalbuphine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00198	0.00212	CcSEcCtD
Nalbuphine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00198	0.00212	CcSEcCtD
Nalbuphine—Headache—Betamethasone—ankylosing spondylitis	0.00197	0.00211	CcSEcCtD
Nalbuphine—Headache—Dexamethasone—ankylosing spondylitis	0.00197	0.00211	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—ankylosing spondylitis	0.00196	0.0021	CcSEcCtD
Nalbuphine—Pruritus—Prednisone—ankylosing spondylitis	0.00193	0.00208	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00188	0.00202	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00187	0.002	CcSEcCtD
Nalbuphine—Nausea—Dexamethasone—ankylosing spondylitis	0.00186	0.002	CcSEcCtD
Nalbuphine—Nausea—Betamethasone—ankylosing spondylitis	0.00186	0.002	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—ankylosing spondylitis	0.00181	0.00195	CcSEcCtD
Nalbuphine—Dizziness—Prednisone—ankylosing spondylitis	0.00181	0.00194	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00181	0.00194	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00181	0.00194	CcSEcCtD
Nalbuphine—Vomiting—Prednisone—ankylosing spondylitis	0.00174	0.00187	CcSEcCtD
Nalbuphine—Rash—Prednisone—ankylosing spondylitis	0.00172	0.00185	CcSEcCtD
Nalbuphine—Dermatitis—Prednisone—ankylosing spondylitis	0.00172	0.00185	CcSEcCtD
Nalbuphine—Headache—Prednisone—ankylosing spondylitis	0.00171	0.00184	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00168	0.00181	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—ankylosing spondylitis	0.00164	0.00176	CcSEcCtD
Nalbuphine—Nausea—Prednisone—ankylosing spondylitis	0.00162	0.00174	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—ankylosing spondylitis	0.00162	0.00173	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—ankylosing spondylitis	0.00151	0.00162	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—ankylosing spondylitis	0.00145	0.00156	CcSEcCtD
Nalbuphine—Rash—Methotrexate—ankylosing spondylitis	0.00144	0.00155	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00144	0.00154	CcSEcCtD
Nalbuphine—Headache—Methotrexate—ankylosing spondylitis	0.00143	0.00154	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—ankylosing spondylitis	0.00136	0.00146	CcSEcCtD
